Corium Announces Proposed Offering of $100 Million of Convertible Senior Notes Pharmaceutical Investing
Asterias Provides Update for its AST-OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury Biotech Investing
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2017 Financial Results Pharmaceutical Investing
Updated Pennsylvania Legislative Study Projects more than 90% Savings in Bay Compliance Costs Biotech Investing
ProQR Announces Results for the Fourth Quarter and Full Year 2017 and Provides Business Update Pharmaceutical Investing
Amicus Therapeutics Announces Full-Year 2017 Financial Results and 2018 Corporate Updates Biotech Investing
BeiGene Announces Approval of REVLIMID® for Newly Diagnosed Multiple Myeloma in China Pharmaceutical Investing
